New Ray Medicine International Holding Limited (SEHK: 6108)
Health Care · Health Care Providers & Services · CN
HK$0.21
-6.70% today · -47.1% 1Y
New Ray Medicine International Holding Limited (SEHK: 6108) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $5.34M and employs 31 people.
Over the last twelve months the share price has lost 47.1%, trading between 0.19 and 0.42.
Tweenvest scores New Ray Medicine International Holding Limited across four factors: quality 59/100, value 55/100, growth 92/100. Its strongest factor is growth.
6108 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.34M
- Revenue (TTM)
- $25.39M
- P/E
- —
- EPS
- -0.09
- Dividend yield
- —
- Beta (5Y)
- -3.90
- 52-week high
- HK$0.42
- 52-week low
- HK$0.19
- Avg volume (3M)
- —
- Shares outstanding
- 200.62M
- Employees
- 31
- Next earnings
- —
About New Ray Medicine International Holding Limited
New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.
- ISIN
- BMG647461372
- Founded
- 2001
- Listed since
- Oct 28, 2013
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pomdoctor LimitedNasdaqGM: POM | $5.95M | $0.63 | -18.51% |
| Basel Medical Group LtdNasdaqCM: BMGL | $5.93M | $3.75 | 0.00% |
| SoftMedx Healthcare LimitedSEHK: 648 | $5.87M | HK$0.43 | +6.17% |
| Aatmaj Healthcare LimitedNSEI: AATMAJ | $5.59M | Rs23.95 | +19.75% |
| ABH Healthcare LimitedNSEI: ABH | $5.28M | Rs44.70 | +7.84% |
| Clearbridge Health LimitedCatalist: 1H3 | $5.03M | S$0.00 | -50.00% |
| Me Today LimitedNZSE: MEE | $4.98M | NZ$0.09 | -1.05% |
| Pa Shun International Holdings LimitedSEHK: 574 | $4.57M | HK$— | — |
Figures last refreshed Oct 11, 2026.